A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Molecular and serological studies of Egyptian strains of rabbit haemorrhagic disease virus and their comparison with vaccine strains
2020
Rev Sci Tech Off Int Epizoot
Vaccination is the major control measure for rabbit haemorrhagic disease virus (RHDV). The co-circulation of different RHDV genotypes in Egypt has led to the need to determine the most effective vaccine strain and the cross-protection between these genotypes. Rabbits seronegative for RHDV were vaccinated with the commercial GI.1a (RHDVa) vaccine strain Giza2006 and the GI.1d (G5) vaccine strain Giza97. The rabbits were challenged three weeks post vaccination with GI.1a (RHDVa) strains Giza2010
doi:10.20506/rst.39.3.3195
pmid:35275119
fatcat:t2rg7ydxvvfspixfrqkwew5ayy